16 May 2024
Job Information
- Organisation/Company
Institute of Materials Science of Barcelona (ICMAB-CSIC)- Department
Direction- Research Field
Pharmacological sciences » Clinical pharmacology
Pharmacological sciences » Pharmacy
Pharmacological sciences » Toxicology- Researcher Profile
Established Researcher (R3)- Country
Spain- Application Deadline
28 Jun 2024 - 12:00 (Europe/Madrid)- Type of Contract
Other- Job Status
Full-time- Hours Per Week
40- Offer Starting Date
15 Jul 2024- Is the job funded through the EU Research Framework Programme?
HE / EIC- Reference Number
101136772- Is the Job related to staff position within a Research Infrastructure?
Yes
Offer Description
Workplace: Molecular Nanoscience and Organic Materials Department, NANOMOL-BIO group (https://icmab.es/mnom/nanomol-bio ); Institut de Ciència de Materials de Barcelona (ICMAB-CSIC). NANOMOL has extensive experience and recognized excellence in the synthesis, processing, and study of molecular and polymeric materials with chemical, electronic, magnetic, and biomedical properties. We continuously generate new knowledge in our basic and applied research projects on the micro and nanostructure of molecular materials. We offer this knowledge to improve the properties of products manufactured in different sectors, such as chemical, pharmaceutical, and electronic, thus contributing to increase their added value. As a department, we actively participate in the implementation of nanotechnology and sustainable and economically efficient technologies for the preparation of advanced functional molecular materials. NANOMOL is a member of the Biomedical Research Network (CIBER) in the area of Bioengineering, Biomaterials, and Nanomedicine (CIBER-BNN); and is awarded with the TECNIO seal, which is given to Catalan research groups with high innovative and technology transfer capabilities. We belong to the Institute of Materials Science of Barcelona (www.icmab.es ), a CSIC research institute. Our facilities are located on the campus of the UAB (Universitat Autònoma de Barcelona). The candidate will work in the Nano4Rare project (Preclinical development of a nanomedicine candidate for Fabry rare disease treatment to enter clinical phase), funded by the Strategic EIC Transition Challenges program from European Innovation Council. As a Nanomedicine Preclinical Researcher, you will play a pivotal role in advancing our project towards clinical phase. Main Tasks: You will manage and execute tasks associated with the preclinical development of a nanomedicine, and the necessary regulatory activities prior FIH clinical trials. |
Requirements
- Research Field
- Pharmacological sciences » Clinical pharmacology
- Education Level
- PhD or equivalent
- Research Field
- Pharmacological sciences » Pharmacy
- Education Level
- PhD or equivalent
- Research Field
- Pharmacological sciences » Toxicology
- Education Level
- PhD or equivalent
Skills/Qualifications
· Strong background in regulatory affairs, particularly in biologicals and drug delivery systems. · Experience in preclinical development, including knowledge of GLP regulations. |
Specific Requirements
· Demonstrated experience in interacting with regulatory agencies and preparing regulatory submissions (e.g. Briefing documents, Scientific advice procedures, Clinical Trial Application…) · Excellent communication and interpersonal skills, with the ability to effectively collaborate with a multidisciplinary partnership · Previous experience in managing cross-functional teams |
- Languages
- ENGLISH
- Level
- Excellent
- Languages
- SPANISH
- Level
- Basic
- Research Field
- Pharmacological sciences » Clinical pharmacologyPharmacological sciences » PharmacyPharmacological sciences » Toxicology
- Years of Research Experience
- More than 10
Internal Application form(s) needed
Nano4Rare preclinical researcher v4.pdf
English
(283.83 KB - PDF)
Download
Additional Information
Benefits
Gross annual salary according to agreement. |
Selection process
Job interviews |
Additional comments
About ICMAB:
|
- Website for additional job details
https://www.linkedin.com/company/nano4rare/
Work Location(s)
- Number of offers available
- 1
- Company/Institute
- Institute of Materials Science of Barcelona (ICMAB-CSIC)
- Country
- Spain
- State/Province
- Catalunya (Barcelona)
- City
- Bellaterra
- Postal Code
- 08193
- Street
- Til·lers, s/n, Campus Bellaterra
Where to apply
[email protected]
Contact
- State/Province
Catalunya/Barcelona- City
Bellaterra- Website
http://www.icmab.es- Street
Campus U.A.B.- Postal Code
08193
[email protected]
STATUS: EXPIRED
Similar Positions
-
Senior Postdoctoral Reseacher Novel Energy Oriented Materials Group, ICN2, Spain, about 19 hours ago
As a flagship research center in nanoscience and nanotechnology, our mission is to open and explore new frontiers of knowledge at the nanoscale, and bring value to society in the form of new under...
-
Senior Postdoctoral Researcher Advanced Electronic Materials And Devices Group, ICN2, Spain, 10 days ago
As a flagship research center in nanoscience and nanotechnology, our mission is to open and explore new frontiers of knowledge at the nanoscale, and bring value to society in the form of new under...
-
Post Doctoral Fellow In Drug Delivery, Nanomedicine & Advanced Therapeutics , ;, Hong Kong, 11 days ago
Post-doctoral Fellow in Drug Delivery, Nanomedicine & Advanced Therapeutics at the Department of Pharmacology and Pharmacy (several posts) (Ref.: 526276) We now invite applicants to join the Scien...
-
Senior Postdoctoral Researcher Nanobioelectronics And Biosensors Group, ICN2, Spain, 10 days ago
As a flagship research center in nanoscience and nanotechnology, our mission is to open and explore new frontiers of knowledge at the nanoscale, and bring value to society in the form of new under...
-
Research Communications Assistant, RMIT University, Australia, 8 days ago
Overview: Based in Barcelona, collaborative and dynamic international team High level proficiency in English and working rights in Spain Full time, fixed term until June 2025 Traineeship position ...
-
Postdoc Position In The Development Of In Vitro Models Of The Bbb To Investigate The Efficacy Of Innovative Biotherapeutics Against Cns Diseases , ETH Zurich, Switzerland, about 20 hours ago
100%, Basel, fixed-term For a collaboration project between the Bio Engineering Laboratory (Department of Biosystems Science and Engineering of ETH Zurich in Basel) and Novartis AG, Basel, Switzer...